The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

Medicare will save approximately 44%, on 15 high-cost medications as a result of the second round of the program’s drug price ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

CMS announced a 44% net savings on 15 high-cost drugs under Medicare, effective January 2027, as part of the Inflation ...

Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round ...

Shares of Novo Nordisk ($NVO) are up 3% at the time of writing after the Centers for Medicare & Medicaid Services (CMS) ...

The U.S. Centers for Medicare and Medicaid Services (CMS) on Tuesday announced that it has secured lower prices for 15 of its ...

The US government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of ...